Literature DB >> 16818657

A novel role for human sulfiredoxin in the reversal of glutathionylation.

Victoria J Findlay1, Danyelle M Townsend, Taylor E Morris, Jacob P Fraser, Lin He, Kenneth D Tew.   

Abstract

Modification of protein cysteine residues by disulfide formation with glutathione (glutathionylation) is a reversible posttranslational modification of critical importance in controlling cell signaling events following oxidative and/or nitrosative stress. Here, we show that human sulfiredoxin, a small redox protein conserved in eukaryotes, can act as a novel regulator of the redox-activated thiol switch in cells by catalyzing deglutathionylation of a number of distinct proteins in response to oxidative and/or nitrosative stress. Actin and protein tyrosine phosphatase 1B were identified in vitro as targets of sulfiredoxin 1 (Srx1)-dependent deglutathionylation and confirmed in vivo by two-dimensional gel electrophoresis analysis. In addition, we show that Srx1-dependent deglutathionylation is functionally relevant through restoration of phosphatase activity. Human sulfiredoxin contains one cysteine residue (Cys(99)) that is conserved in all family members. Mutation of the cysteine residue inhibits deglutathionylation but did not affect its capacity to bind intracellular proteins. Furthermore, sulfiredoxin is not an acceptor molecule for the GS(-) moiety during the reaction process. Using two-dimensional gel electrophoresis, we identified multiple protein targets in vivo that are deglutathionylated by sulfiredoxin following oxidative and/or nitrosative stress. This novel deglutathionylation function of sulfiredoxin suggests it has a central role in redox control with potential implications in cell signaling.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16818657      PMCID: PMC6361143          DOI: 10.1158/0008-5472.CAN-06-0484

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  83 in total

Review 1.  Redox platforms in cancer drug discovery and development.

Authors:  Kenneth D Tew; Danyelle M Townsend
Journal:  Curr Opin Chem Biol       Date:  2010-11-11       Impact factor: 8.822

2.  Sulphiredoxin plays peroxiredoxin-dependent and -independent roles via the HOG signalling pathway in Cryptococcus neoformans and contributes to fungal virulence.

Authors:  Rajendra Upadhya; Hyelim Kim; Kwang-Woo Jung; Goun Park; Woei Lam; Jennifer K Lodge; Yong-Sun Bahn
Journal:  Mol Microbiol       Date:  2013-10-03       Impact factor: 3.501

Review 3.  Mechanisms of altered redox regulation in neurodegenerative diseases--focus on S--glutathionylation.

Authors:  Elizabeth A Sabens Liedhegner; Xing-Huang Gao; John J Mieyal
Journal:  Antioxid Redox Signal       Date:  2012-01-06       Impact factor: 8.401

Review 4.  The peroxiredoxin repair proteins.

Authors:  Thomas J Jönsson; W Todd Lowther
Journal:  Subcell Biochem       Date:  2007

Review 5.  S-glutathionylation of ion channels: insights into the regulation of channel functions, thiol modification crosstalk, and mechanosensing.

Authors:  Yang Yang; Xin Jin; Chun Jiang
Journal:  Antioxid Redox Signal       Date:  2013-08-20       Impact factor: 8.401

6.  Stabilization of the nitric oxide (NO) prodrugs and anticancer leads, PABA/NO and Double JS-K, through incorporation into PEG-protected nanoparticles.

Authors:  Varun Kumar; Sam Y Hong; Anna E Maciag; Joseph E Saavedra; Douglas H Adamson; Robert K Prud'homme; Larry K Keefer; Harinath Chakrapani
Journal:  Mol Pharm       Date:  2010-02-01       Impact factor: 4.939

7.  Protein cysteine sulfinic acid reductase (sulfiredoxin) as a regulator of cell proliferation and drug response.

Authors:  K Lei; D M Townsend; K D Tew
Journal:  Oncogene       Date:  2008-05-05       Impact factor: 9.867

8.  Nitrosative stress-induced s-glutathionylation of protein disulfide isomerase leads to activation of the unfolded protein response.

Authors:  Danyelle M Townsend; Yefim Manevich; Lin He; Ying Xiong; Robert R Bowers; Steven Hutchens; Kenneth D Tew
Journal:  Cancer Res       Date:  2009-09-22       Impact factor: 12.701

Review 9.  r

Authors:  Jacqueline S Womersley; Danyelle M Townsend; Peter W Kalivas; Joachim D Uys
Journal:  Eur J Neurosci       Date:  2018-09-24       Impact factor: 3.386

10.  S-glutathionylation impairs signal transducer and activator of transcription 3 activation and signaling.

Authors:  Yi Xie; Sutapa Kole; Patricia Precht; Michael J Pazin; Michel Bernier
Journal:  Endocrinology       Date:  2008-11-06       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.